X
IRWD icon

Xponance’s Ironwood Pharmaceuticals IRWD Stock Holding History

Xponance’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.7K Buy
15,599
+1,262
+9% +$4.86K ﹤0.01% 1763
2026
Q1 		$50.3K Buy
14,337
+1,918
+15% +$7.86K ﹤0.01% 1632
2025
Q4 		$41.9K Buy
12,419
+80
+0.6% +$208 ﹤0.01% 1534
2025
Q3 		$16.2K Hold
12,339
– – ﹤0.01% 1523
2025
Q2 		$8.85K Buy
12,339
+846
+7% +$664 ﹤0.01% 1507
2025
Q1 		$16.9K Buy
11,493
+183
+2% +$436 ﹤0.01% 1432
2024
Q4 		$50.1K Buy
+11,310
New +$45.9K ﹤0.01% 1402
2024
Q2 		– Sell
-14,229
Closed -$124K – 1343
2024
Q1 		$124K Buy
14,229
+73
+0.5% +$886 ﹤0.01% 1228
2023
Q4 		$162K Sell
14,156
-755
-5% -$7.47K ﹤0.01% 1178
2023
Q3 		$144K Buy
+14,911
New +$146K ﹤0.01% 1145

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Xponance's IRWD Position: Q2 2026 in Review

Xponance increased its Ironwood Pharmaceuticals (IRWD) stake by 8.8% in Q2 2026, buying an estimated $4.86K and bringing the position to 15,599 shares worth $65.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

Xponance first reported a position in IRWD in Q3 2023 and has held it in 10 quarters since. The position peaked at $162K in Q4 2023. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Xponance held 15,599 shares of Ironwood Pharmaceuticals worth $65.7K as of Q2 2026.
  • Xponance bought 1,262 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $4.86K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1763 holding.
  • Xponance first reported a position in Ironwood Pharmaceuticals in Q3 2023 and has held it in 10 quarters since.
  • Xponance's Ironwood Pharmaceuticals position peaked at $162K in Q4 2023.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.